System and method for detecting neurological disease
A system and method of detecting eye movements of a subject for the diagnosis of neurological disorders. The method includes tracking eye movements of the subject, identifying microsaccades from the tracked eye movements, and characterizing microsaccade dynamics of the identified microsaccades to determine one or more parameters, such as microsaccade direction, microsaccade velocity, microsaccade magnitude, microsaccadic peak velocity-magnitude relationship, microsaccade duration, and intersaccadic intervals. The method also includes comparing the one or more determined parameters with a corresponding control parameter, assessing the comparison to determine differences between the one or more determined parameters and the corresponding control parameters, and generating a report including the diagnosis of neurological disorder based on the assessment.
1. A method of diagnosing oculomotor disease in a subject, the oculomotor disease being one of Alzheimer's disease and Mild Cognitive Impairment, the method comprising:
receiving tracked eye movements of the subject from an eye tracking device;
identifying microsaccades from the tracked eye movements;
characterizing dynamics of the identified microsaccades, the dynamics including microsaccade direction;
comparing the characterized dynamics to corresponding microsaccade dynamics;
assessing the comparison to determine differences between the characterized dynamics and the corresponding microsaccade dynamics; and
generating a report including a diagnosis related to oculomotor disease in the subject based on the assessment.
2. The method of claim 1 , wherein comparing the characterized dynamics to corresponding microsaccade dynamics includes comparing an average microsaccade direction in the characterized dynamics to an average microsaccade direction in the corresponding microsaccade dynamics.
3. The method of claim 2 , wherein the corresponding microsaccade dynamics are from a healthy subject.
4. The method of claim 3 , wherein the report includes a diagnosis that oculomotor disease is present in the subject when the average microsaccade direction in the characterized dynamics is significantly less horizontal than the average microsaccade direction in the corresponding microsaccade dynamics.
5. The method of claim 3 , wherein the report includes a diagnosis of a severity of oculomotor disease in the subject based on the differences.
6. The method of claim 3 , wherein the report includes a diagnosis of a susceptibility to oculomotor disease in the subject based on the differences.
7. The method of claim 2 , wherein the corresponding microsaccade dynamics are previously tracked from the subject.
8. The method of claim 7 , wherein the report includes a diagnosis related to one of progression of oculomotor disease and response to treatment for oculomotor disease based on a magnitude of the differences.
9. The method of claim 2 , wherein the dynamics further include one or more of microsaccade magnitude, microsaccade velocity, microsaccade peak velocity-magnitude relationship, microsaccade duration, and intersaccadic intervals.
10. The method of claim 1 , wherein receiving tracked eye movements includes receiving binocularly recorded eye movements.
11. The method of claim 1 and further comprising presenting a visual stimulus to the subject.
12. The method of claim 11 and further comprising tracking the eye movements of the subject as the subject fixates on the visual stimulus.
13. The method of claim 1 , wherein the microsaccade direction is measured as a deviation from horizontal.
14. The method of claim 1 and further comprising one of displaying the report through a display of a host device and storing the report in memory of the host device.
15. A method of diagnosing oculomotor disease in a subject, the oculomotor disease being one of Alzheimer's disease and Mild Cognitive Impairment, the method comprising:
receiving tracked eye movements of the subject from an eye tracking device;
identifying microsaccades from the tracked eye movements;
measuring an average microsaccade direction of the identified microsaccades as a deviation from horizontal;
comparing the deviation from horizontal to one of a threshold value, a previous deviation from horizontal, and a normal deviation from horizontal; and
generating a report including a diagnosis related to oculomotor disease in the subject based on the comparison.
16. The method of claim 15 , wherein comparing includes determining a difference between the deviation from horizontal and the normal deviation from horizontal, the normal deviation from horizontal being obtained from eye movements of normal subjects.
17. The method of claim 16 , wherein the report includes a diagnosis that the oculomotor disease is present in the subject when the difference greater than or equal to a threshold.
18. The method of claim 16 , wherein the report includes a diagnosis of one of a severity of and a susceptibility to the oculomotor disease based on the difference.
19. The method of claim 15 , wherein comparing includes determining a difference between the deviation from horizontal and the previous deviation from horizontal, the previous deviation from horizontal being obtained from previously tracked eye movements of the subject.
20. The method of claim 19 , wherein the report includes a diagnosis of one of a progression of and a response to treatment from the oculomotor disease based on the difference.